| JVLCX | RMEBX | JVLCX / RMEBX | |
| Total Expense Ratio | 1.71 | 1.07 | 160% |
| Annual Report Gross Expense Ratio | 1.72 | 1.07 | 161% |
| Fund Existence | 17 years | 11 years | - |
| Gain YTD | 11.194 | 9.617 | 116% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 250 | 400% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 18.4B | 112B | 16% |
| Annual Yield % from dividends | 0.02 | 1.03 | 2% |
| Returns for 1 year | 9.55 | 7.85 | 122% |
| Returns for 3 years | 18.52 | 28.25 | 66% |
| Returns for 5 years | 20.02 | 45.24 | 44% |
| Returns for 10 years | 40.67 | 88.81 | 46% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| WTID | 12.01 | 0.07 | +0.59% |
| MicroSectors™ Energy -3X Invrs Lvrgd ETN | |||
| KEMX | 36.94 | 0.20 | +0.54% |
| KraneShares MSCI Em Mkts ex CHN ETF | |||
| USTB | 50.80 | 0.02 | +0.05% |
| VictoryShares Short-Term Bond ETF | |||
| PJP | 107.85 | -0.23 | -0.21% |
| Invesco Pharmaceuticals ETF | |||
| WSML | 30.77 | -0.10 | -0.32% |
| iShares MSCI World Small-Cap ETF | |||